Andrew Hirsch - 18 Sep 2023 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
President & CEO, Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
18 Sep 2023
Net transactions value
$0
Form type
4
Filing time
19 Sep 2023, 19:24:44 UTC
Previous filing
31 Aug 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Award $0 +489,600 $0.000000 489,600 18 Sep 2023 Common Stock 489,600 $2.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on September 18, 2025, subject to the Reporting Person's continued service on such date.